Alma Glenmede US Large Cap Growth Equity Fund
- Alma Glenmede US Large Cap Growth Equity Fund aims to achieve above-benchmark long-term return through capital appreciation of US large cap growth stocks, and by limiting downside risk.
- The fund’s management is delegated to Glenmede Investment Management LP
Cumulative Performance (%)
Fund Inception 12 January 2018
The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance quoted. The investment return and the principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost.
Strategy & Manager
Investment objective: to achieve above-benchmark long-term return through capital appreciation of undervalued US large cap growth stocks, and by limiting downside risk
- Investment strategy based on valuation, fundamental, earnings and technical characteristics
- Quantitatively-based investment process with stringent risk controls
- Focuses on underperformance risk as much as out performance opportunity
- Portfolio of typically 60-90 names
Portfolio managed by Glenmede Investment Management LP, a Philadelphia based SEC regulated investment manager with over $15bn AUM, part of the Glenmede group (approx. $40 bn in assets).
- 48 employees, all located in Philadelphia, PA
- 25 investment professionals; senior portfolio managers with an average 25 years of experience, including 15 years at Glenmede
- Vladimir de Vassal, director of Quantitative Research for Glenmede Investment Management LP, leads the team managing Glenmede’s quantitatively based equity portfolios, including the Large Cap Growth strategy
Vladimir de Vassal, CFA Director of Quantitative Research
Mr. de Vassal leads the team managing Glenmede’s quantitatively based equity portfolios, including the Large Cap Core strategy, and provides proprietary research and analytical support to a range of domestic and International funds, private equity, the Pew Charitable Trusts, and high-net-worth clients of the Glenmede Trust Company.
Mr. de Vassal joined Glenmede in 1998, after serving in senior analytical positions with CoreStates Investment Advisors and CoreStates Financial. He received a B.S. with highest honors from Drexel University in 1982, majoring in both Finance and Accounting. He received his M.B.A., with concentration in Investment Management, from Drexel University in 1987, and earned his Chartered Financial Analyst® designation in 1992. Mr. de Vassal is a member of the CFA Institute.
Paul T. Sullivan, CFA Portfolio Manager
Mr. Sullivan manages the Glenmede Large Cap Core and Large Cap Growth mutual funds, as well as separate accounts for institutional clients. His responsibilities also include analysis utilizing Glenmede’s quantitative stock selection models, and their continuing enhancement.
Mr. Sullivan joined Glenmede from SEI Investments in 1994. He received his B.S. in Business Administration from Bloomsburg University, and his M.B.A. from St. Joseph’s University. He holds the Chartered Financial Analyst® designation, and is a member of the CFA Society of Philadelphia and the CFA Institute.
Alexander R. Atanasiu, CFA Portfolio Manager, Quantitative Equity Officer
Mr. Atanasiu’s responsibilities include Glenmede’s proprietary stock ranking screening tools, multifactor stock optimizations, leading indicator analysis, and development of quantitative analytical tools for analysts and portfolio managers. He also provides support for the management of several of Glenmede’s quantitatively-based equity strategies, including long/short funds.
Mr. Atanasiu joined Glenmede in 2005. He holds dual degrees in engineering and physics from Swarthmore College, and received his M.B.A. with distinction from New York University’s Stern School of Business, with concentrations in quantitative finance and business analytics. He received his Chartered Financial Analyst® designation in 2009.
Statistics & Commentary
The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
Sector Breakdown as a % of AUMas of 31/10/2019
Portfolio Characteristicsas of 31/10/2019
|No. of securities||71||529|
|Projected P/E Ratio||18.1x||24.0x|
|Price/ Normal Earnings||20.5x||27.2x|
|Price / Book||5.7x||7.6x|
|Projected EPS Growth||10.9||13.8|
|Weighted Average Market Cap ($ bn)||153.3||315.0|
|Median Market Cap ($ bn)||30.7||13.2|
|Active share (%, vs Russell 1000)||70.9|
|Active share (%, vs S&P 500)||73.8|
Top 10 Position Detailsas of 31/10/2019
|Security name||Sector||% AUM|
|VISA INC-CLASS A SHARES||Information Technology||2.82|
|CDW CORP/DE||Information Technology||2.69|
|LAM RESEARCH CORP||Information Technology||2.63|
|MICROSOFT CORP||Information Technology||2.51|
|APPLE INC||Information Technology||2.45|
|BIOGEN INC||Health Care||2.45|
|PAYPAL HOLDINGS INC-W/I||Information Technology||2.37|
|ROSS STORES INC||Consumer Discretionary||2.28|
|CELGENE CORP||Health Care||2.23|
|UNITEDHEALTH GROUP INC||Health Care||2.21|
Investment Manager's Commentaryas of 31/10/2019
Market Review and Outlook
For October 2019, S&P 500 and Russell 1000 Growth Indexes had total returns of +2.2% and +2.8%, respectively. Equity markets were boosted by strong third quarter earnings reports with 76% and 80% of the S&P 500 and Russell 1000 Growth companies reporting positive surprises, respectively. The Russell 1000 Growth performance was skewed with four companies (AAPL +11.1%, FB +7.6%, MSFT +3.1%, GOOG +3.4%) contributing over 50% (146 basis points) of the overall Russell 1000 Growth total return. Although the strategy had exposure to all four companies, there was a negative impact from relative underweightings due to stock specific weight constraints. The average stock in the Russell 1000 Growth index had a total return of about +1.5%. The top and worst performing sectors were health care (+6.0%) and energy (-2.5%), respectively. The strategy had positive contributions from multi-factor stock selection models, including biases towards stocks with relatively lower valuations. Industry group targets had a favorable effect from relative overweightings in health care stocks. The strategy reflected stock selection outperformance in four of nine sectors. The most positive relative contributions were in Health Care and Industrials sectors. The most negative relative contributions were in the Communications Services and Information Technology sectors.
The initial U.S. real GDP estimate for 3rd Quarter was 1.9% versus 2.0% for 2nd Qtr 2019. The 3rd Qtr GDP reflected slower growth in personal consumption expenditures (2.9% vs. 4.6% in 2Q) and state/local government spending offset by higher exports and residential fixed investments. Nonresidential fixed investments declined -3% versus -1% in 2nd Quarter. Domestic growth has been supported by high employment, positive consumer sentiment and deregulation. Many economists project positive real GDP growth of 1.5%-2.5% for fourth quarter 2019 and 2020. However, trade disputes, unfavorable manufacturing trends and weak global growth are risks to U.S. economic growth. Currently, our industry group indicators target overweightings in financials/health care and underweightings in consumer discretionary/utilities, respectively.
Facts & Documents
Fund Domicile: Luxembourg
Management Fee: 0.75% p.a. for I shares
Fund Type: UCITS SICAV
Fund Launch: 12 January 2018
Base Currency: USD
Depositary, Administrator, Transfert Agent: BNP Paribas Securities Services (LU)
Dealing: Each day with a 1-day notice
Cut-off time: 12 pm CET
Management Company: Alma Capital Investment Management
Investment Manager: Glenmede Investment Management LP (US)
Fund Managers: Vladimir de Vassal , Paul T Sullivan Alexander R. Atanasiu
Countries where the fund is registered:
Institutional USD Capitalisation share class
ISIN: LU1687386091 Ticker: AGULCIA LX Launch: 12 Jan 2018
available upon request